ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-OR066

Murine Diabetic Nephropathy at Single Cell Resolution

Session Information

Category: Diabetic Kidney Disease

  • 601 Diabetic Kidney Disease: Basic

Authors

  • Wu, Haojia, Washington University School of Medicine, Saint Louis, Missouri, United States
  • Gonzalez-Villalobos, Romer Andres, Janssen Research & Development, Cardiovascular Metabolism, Boston, Massachusetts, United States
  • Yao, Xiang, Janssen Research & Development, Cardiovascular Metabolism, Boston, Massachusetts, United States
  • Rankin, Matthew M., Janssen Research & Development, Cardiovascular Metabolism, Boston, Massachusetts, United States
  • Kirita, Yuhei, Washington University School of Medicine, Saint Louis, Missouri, United States
  • Breyer, Matthew, Janssen Research & Development, Cardiovascular Metabolism, Boston, Massachusetts, United States
  • Humphreys, Benjamin D., Washington University School of Medicine, Saint Louis, Missouri, United States

Group or Team Name

  • The Humphreys Lab
Background

Diabetic nephropathy (DN) is the most common cause of ESRD, but the transcriptional changes driving disease progression at the single cell level remain undefined. We hypothesized that single nucleus RNA-seq could provide insight into the cellular mechanisms of diabetic nephropathy.

Methods

We collected urine and kidney samples from control(n=2) and db/db(n=4) female mice at 17 weeks. We generated a total of 70,437 single nucleus transcriptomes and performed a comprehensive bioinformatics analysis.

Results

db/db mice had 255±35 µg/mg urine Alb:creatinine ratio compared to 24±6 in control. On average we detected 2,940 unique genes/nucleus. By unbiased clustering, we could identify 18 major cell types representing all major cell types, including macula densa, with differential expression of hundreds of genes across all clusters. Diabetic kidney had higher leukocyte infiltration including T cells, dendritic cells and macrophages. Diabetic macrophages upregulated the receptor Plxdc2, whose ligand PEDF ameliorates DN when administered exogenously. We generated a detailed diabetic glomerular intercellular communication map between podocytes, glomerular endothelium, mesangium and Cdh6+ parietal epithelia. This revealed podocyte – parietal epithelial cell signaling via b-catenin suppressive Igfbp4-Lrp6 signaling among others. We identified evidence for compensatory gene expression to combat podocyte damage, including downregulation of protein kinase C epsilon and upregulation of type 1 adenylate cyclase, proteins known to mediate susceptibility to proteinuria. Other upregulated podocyte genes included angiogenic EphA6 and Shroom3, a GWAS hit for CKD. Unexpectedly, diabetic stroma cells showed the largest gene expression changes including genes related to integrin linked kinase, cell adhesion and calcium signaling.

Conclusion

This is the first comprehensive single nucleus transcriptional atlas of a mouse model of DN. We demonstrate the utility of this approach by revealing (1) activated macrophage recruitment, (2) detailed diabetic glomerulus intercellular communication, (3) podocyte-specific expression of proteinuria susceptibility genes and (4) stromal cell activation.

Funding

  • Commercial Support – Janssen Pharmaceuticals